Illinois Compiled Statutes
Information maintained by the Legislative Reference Bureau
Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process. Recent laws may not yet be included in the ILCS database, but they are found on this site as Public Acts
soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the Guide
Because the statute database is maintained primarily for legislative drafting purposes, statutory changes are sometimes included in the statute database before they take effect. If the source note at the end of a Section of the statutes includes a Public Act that has not yet taken effect, the version of the law that is currently in effect may have already been removed from the database and you should refer to that Public Act to see the changes made to the current law.
CRIMINAL OFFENSES720 ILCS 570/Art. I
(720 ILCS 570/) Illinois Controlled Substances Act.
(720 ILCS 570/Art. I heading)
720 ILCS 570/100
(720 ILCS 570/100)
(from Ch. 56 1/2, par. 1100)
It is the intent of the General Assembly, recognizing the rising
incidence in the abuse of drugs and other dangerous substances and its
resultant damage to the peace, health, and welfare of the citizens of
Illinois, to provide a system of control over the distribution and use of
controlled substances which will more effectively: (1) limit access of such
substances only to those persons who have demonstrated an appropriate sense
of responsibility and have a lawful and legitimate reason to possess them;
(2) deter the unlawful and destructive abuse of controlled substances; (3)
penalize most heavily the illicit traffickers or profiteers of controlled
substances, who propagate and perpetuate the abuse of such substances with
reckless disregard for its consumptive consequences upon every element of
society; (4) acknowledge the functional and consequential differences
between the various types of controlled substances and provide for
correspondingly different degrees of control over each of the various
types; (5) unify where feasible and codify the efforts of this State to
conform with the regulatory systems of the Federal government; and (6) provide law enforcement authorities with
the necessary resources to make this system efficacious.
It is not the intent of the General Assembly to treat the unlawful user
or occasional petty distributor of controlled substances with the same
severity as the large-scale, unlawful purveyors and traffickers of
However, it is recognized that persons who violate this Act with respect to
the manufacture, delivery, possession with intent to deliver, or possession of
more than one type of controlled substance listed herein may accordingly
receive multiple convictions and sentences under each Section of this Act.
To this end, guidelines have been provided, along
with a wide latitude in sentencing discretion, to enable the sentencing
court to order penalties in each case which are appropriate for the
purposes of this Act.
(Source: P.A. 97-334, eff. 1-1-12.)
720 ILCS 570/101
(720 ILCS 570/101)
(from Ch. 56 1/2, par. 1101)
This Act shall be known as and may be cited as the "
Illinois Controlled Substances Act.
(Source: P.A. 77-757.)
720 ILCS 570/102
(720 ILCS 570/102)
(from Ch. 56 1/2, par. 1102)
As used in this Act, unless the context
(a) "Addict" means any person who habitually uses any drug, chemical,
substance or dangerous drug other than alcohol so as to endanger the public
morals, health, safety or welfare or who is so far addicted to the use of a
dangerous drug or controlled substance other than alcohol as to have lost
the power of self control with reference to his or her addiction.
(b) "Administer" means the direct application of a controlled
substance, whether by injection, inhalation, ingestion, or any other
means, to the body of a patient, research subject, or animal (as
defined by the Humane Euthanasia in Animal Shelters Act) by:
(1) a practitioner (or, in his or her presence, by
his or her authorized agent),
(2) the patient or research subject pursuant to an
(3) a euthanasia technician as defined by the Humane
Euthanasia in Animal Shelters Act.
(c) "Agent" means an authorized person who acts on behalf of or at
the direction of a manufacturer, distributor, dispenser, prescriber, or practitioner. It does not
include a common or contract carrier, public warehouseman or employee of
the carrier or warehouseman.
(c-1) "Anabolic Steroids" means any drug or hormonal substance,
chemically and pharmacologically related to testosterone (other than
estrogens, progestins, corticosteroids, and dehydroepiandrosterone),
(iv) 1-androstenediol (3[beta],
(v) 1-androstenediol (3[alpha],
(xi) bolasterone (7[alpha],17a-dimethyl-17[beta]-
(xii) boldenone (17[beta]-hydroxyandrost-
(xiii) boldione (androsta-1,4-
(xiv) calusterone (7[beta],17[alpha]-dimethyl-17
(xv) clostebol (4-chloro-17[beta]-
(xvi) dehydrochloromethyltestosterone (4-chloro-
(xvii) desoxymethyltestosterone (17[alpha]-methyl-5[alpha]
(xviii) [delta]1-dihydrotestosterone (a.k.a.
(xix) 4-dihydrotestosterone (17[beta]-hydroxy-
(xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl-
(xxi) ethylestrenol (17[alpha]-ethyl-17[beta]-
(xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl-
(xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha],
(xxiv) furazabol (17[alpha]-methyl-17[beta]-
(xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy-
(xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]-
(xxviii) mestanolone (17[alpha]-methyl-17[beta]-
(xxix) mesterolone (1amethyl-17[beta]-hydroxy-
(xxx) methandienone (17[alpha]-methyl-17[beta]-
(xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]-
(xxxii) methenolone (1-methyl-17[beta]-hydroxy-
(xxxiii) 17[alpha]-methyl-3[beta], 17[beta]-
(xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]-
(xxxvii) methyldienolone (17[alpha]-methyl-17[beta]-
(xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]-
(xxxix) methyltestosterone (17[alpha]-methyl-17[beta]-
(xl) mibolerone (7[alpha],17a-dimethyl-17[beta]-
(xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one),
(xliii) 19-nor-4-androstenediol (3[beta], 17[beta]-
(xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]-
(xlv) 19-nor-5-androstenediol (3[beta], 17[beta]-
(xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]-
(xlviii) 19-nor-4-androstenedione (estr-4-
(xlix) 19-nor-5-androstenedione (estr-5-
(l) norbolethone (13[beta], 17a-diethyl-17[beta]-
(li) norclostebol (4-chloro-17[beta]-
(lii) norethandrolone (17[alpha]-ethyl-17[beta]-
(liii) normethandrolone (17[alpha]-methyl-17[beta]-
(liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-
(lv) oxymesterone (17[alpha]-methyl-4,17[beta]-
(lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene-
(lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy-
(lviii) stenbolone (17[beta]-hydroxy-2-methyl-
(lix) testolactone (13-hydroxy-3-oxo-13,17-
(lx) testosterone (17[beta]-hydroxyandrost-
(lxi) tetrahydrogestrinone (13[beta], 17[alpha]-
(lxii) trenbolone (17[beta]-hydroxyestr-4,9,
Any person who is otherwise lawfully in possession of an anabolic
steroid, or who otherwise lawfully manufactures, distributes, dispenses,
delivers, or possesses with intent to deliver an anabolic steroid, which
anabolic steroid is expressly intended for and lawfully allowed to be
administered through implants to livestock or other nonhuman species, and
which is approved by the Secretary of Health and Human Services for such
administration, and which the person intends to administer or have
administered through such implants, shall not be considered to be in
unauthorized possession or to unlawfully manufacture, distribute, dispense,
deliver, or possess with intent to deliver such anabolic steroid for
purposes of this Act.
(d) "Administration" means the Drug Enforcement Administration,
United States Department of Justice, or its successor agency.
(d-5) "Clinical Director, Prescription Monitoring Program" means a Department of Human Services administrative employee licensed to either prescribe or dispense controlled substances who shall run the clinical aspects of the Department of Human Services Prescription Monitoring Program and its Prescription Information Library.
(d-10) "Compounding" means the preparation and mixing of components, excluding flavorings, (1) as the result of a prescriber's prescription drug order or initiative based on the prescriber-patient-pharmacist relationship in the course of professional practice or (2) for the purpose of, or incident to, research, teaching, or chemical analysis and not for sale or dispensing. "Compounding" includes the preparation of drugs or devices in anticipation of receiving prescription drug orders based on routine, regularly observed dispensing patterns. Commercially available products may be compounded for dispensing to individual patients only if both of the following conditions are met: (i) the commercial product is not reasonably available from normal distribution channels in a timely manner to meet the patient's needs and (ii) the prescribing practitioner has requested that the drug be compounded.
(e) "Control" means to add a drug or other substance, or immediate
precursor, to a Schedule whether by
transfer from another Schedule or otherwise.
(f) "Controlled Substance" means (i) a drug, substance, or immediate
precursor in the Schedules of Article II of this Act or (ii) a drug or other substance, or immediate precursor, designated as a controlled substance by the Department through administrative rule. The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are
defined or used in the Liquor Control Act and the Tobacco Products Tax
(f-5) "Controlled substance analog" means a substance:
(1) the chemical structure of which is substantially
similar to the chemical structure of a controlled substance in Schedule I or II;
(2) which has a stimulant, depressant, or
hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II; or
(3) with respect to a particular person, which such
person represents or intends to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II.
(g) "Counterfeit substance" means a controlled substance, which, or
the container or labeling of which, without authorization bears the
trademark, trade name, or other identifying mark, imprint, number or
device, or any likeness thereof, of a manufacturer, distributor, or
dispenser other than the person who in fact manufactured, distributed,
or dispensed the substance.
(h) "Deliver" or "delivery" means the actual, constructive or
attempted transfer of possession of a controlled substance, with or
without consideration, whether or not there is an agency relationship.
(i) "Department" means the Illinois Department of Human Services (as
successor to the Department of Alcoholism and Substance Abuse) or its successor agency.
(k) "Department of Corrections" means the Department of Corrections
of the State of Illinois or its successor agency.
(l) "Department of Financial and Professional Regulation" means the Department
of Financial and Professional Regulation of the State of Illinois or its successor agency.
(m) "Depressant" means any drug that (i) causes an overall depression of central nervous system functions, (ii) causes impaired consciousness and awareness, and (iii) can be habit-forming or lead to a substance abuse problem, including but not limited to alcohol, cannabis and its active principles and their analogs, benzodiazepines and their analogs, barbiturates and their analogs, opioids (natural and synthetic) and their analogs, and chloral hydrate and similar sedative hypnotics.
(o) "Director" means the Director of the Illinois State Police or his or her designated agents.
(p) "Dispense" means to deliver a controlled substance to an
ultimate user or research subject by or pursuant to the lawful order of
a prescriber, including the prescribing, administering, packaging,
labeling, or compounding necessary to prepare the substance for that
(q) "Dispenser" means a practitioner who dispenses.
(r) "Distribute" means to deliver, other than by administering or
dispensing, a controlled substance.
(s) "Distributor" means a person who distributes.
(t) "Drug" means (1) substances recognized as drugs in the official
United States Pharmacopoeia, Official Homeopathic Pharmacopoeia of the
United States, or official National Formulary, or any supplement to any
of them; (2) substances intended for use in diagnosis, cure, mitigation,
treatment, or prevention of disease in man or animals; (3) substances
(other than food) intended to affect the structure of any function of
the body of man or animals and (4) substances intended for use as a
component of any article specified in clause (1), (2), or (3) of this
subsection. It does not include devices or their components, parts, or
(t-5) "Euthanasia agency" means
an entity certified by the Department of Financial and Professional Regulation for the
purpose of animal euthanasia that holds an animal control facility license or
shelter license under the Animal Welfare Act. A euthanasia agency is
authorized to purchase, store, possess, and utilize Schedule II nonnarcotic and
Schedule III nonnarcotic drugs for the sole purpose of animal euthanasia.
(t-10) "Euthanasia drugs" means Schedule II or Schedule III substances
(nonnarcotic controlled substances) that are used by a euthanasia agency for
the purpose of animal euthanasia.
(u) "Good faith" means the prescribing or dispensing of a controlled
substance by a practitioner in the regular course of professional
treatment to or for any person who is under his or her treatment for a
pathology or condition other than that individual's physical or
psychological dependence upon or addiction to a controlled substance,
except as provided herein: and application of the term to a pharmacist
shall mean the dispensing of a controlled substance pursuant to the
prescriber's order which in the professional judgment of the pharmacist
is lawful. The pharmacist shall be guided by accepted professional
standards including, but not limited to the following, in making the
(1) lack of consistency of prescriber-patient
(2) frequency of prescriptions for same drug by one
prescriber for large numbers of patients,
(3) quantities beyond those normally prescribed,
(4) unusual dosages (recognizing that there may be
clinical circumstances where more or less than the usual dose may be used legitimately),
(5) unusual geographic distances between patient,
pharmacist and prescriber,
(6) consistent prescribing of habit-forming drugs.
(u-0.5) "Hallucinogen" means a drug that causes markedly altered sensory perception leading to hallucinations of any type.
(u-1) "Home infusion services" means services provided by a pharmacy in
compounding solutions for direct administration to a patient in a private
residence, long-term care facility, or hospice setting by means of parenteral,
intravenous, intramuscular, subcutaneous, or intraspinal infusion.
(u-5) "Illinois State Police" means the State
Police of the State of Illinois, or its successor agency.
(v) "Immediate precursor" means a substance:
(1) which the Department has found to be and by rule
designated as being a principal compound used, or produced primarily for use, in the manufacture of a controlled substance;
(2) which is an immediate chemical intermediary used
or likely to be used in the manufacture of such controlled substance; and
(3) the control of which is necessary to prevent,
curtail or limit the manufacture of such controlled substance.
(w) "Instructional activities" means the acts of teaching, educating
or instructing by practitioners using controlled substances within
educational facilities approved by the State Board of Education or
its successor agency.
(x) "Local authorities" means a duly organized State, County or
Municipal peace unit or police force.
(y) "Look-alike substance" means a substance, other than a controlled
substance which (1) by overall dosage unit appearance, including shape,
color, size, markings or lack thereof, taste, consistency, or any other
identifying physical characteristic of the substance, would lead a reasonable
person to believe that the substance is a controlled substance, or (2) is
expressly or impliedly represented to be a controlled substance or is
distributed under circumstances which would lead a reasonable person to
believe that the substance is a controlled substance. For the purpose of
determining whether the representations made or the circumstances of the
distribution would lead a reasonable person to believe the substance to be
a controlled substance under this clause (2) of subsection (y), the court or
other authority may consider the following factors in addition to any other
factor that may be relevant:
(a) statements made by the owner or person in control
of the substance concerning its nature, use or effect;
(b) statements made to the buyer or recipient that
the substance may be resold for profit;
(c) whether the substance is packaged in a manner
normally used for the illegal distribution of controlled substances;
(d) whether the distribution or attempted
distribution included an exchange of or demand for money or other property as consideration, and whether the amount of the consideration was substantially greater than the reasonable retail market value of the substance.
Clause (1) of this subsection (y) shall not apply to a noncontrolled
substance in its finished dosage form that was initially introduced into
commerce prior to the initial introduction into commerce of a controlled
substance in its finished dosage form which it may substantially resemble.
Nothing in this subsection (y) prohibits the dispensing or distributing
of noncontrolled substances by persons authorized to dispense and
distribute controlled substances under this Act, provided that such action
would be deemed to be carried out in good faith under subsection (u) if the
substances involved were controlled substances.
Nothing in this subsection (y) or in this Act prohibits the manufacture,
preparation, propagation, compounding, processing, packaging, advertising
or distribution of a drug or drugs by any person registered pursuant to
Section 510 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
(y-1) "Mail-order pharmacy" means a pharmacy that is located in a state
of the United States that delivers, dispenses or
distributes, through the United States Postal Service or other common
carrier, to Illinois residents, any substance which requires a prescription.
(z) "Manufacture" means the production, preparation, propagation,
compounding, conversion or processing of a controlled substance other than methamphetamine, either
directly or indirectly, by extraction from substances of natural origin,
or independently by means of chemical synthesis, or by a combination of
extraction and chemical synthesis, and includes any packaging or
repackaging of the substance or labeling of its container, except that
this term does not include:
(1) by an ultimate user, the preparation or
compounding of a controlled substance for his or her own use; or
(2) by a practitioner, or his or her authorized agent
under his or her supervision, the preparation, compounding, packaging, or labeling of a controlled substance:
(a) as an incident to his or her administering or
dispensing of a controlled substance in the course of his or her professional practice; or
(b) as an incident to lawful research, teaching
or chemical analysis and not for sale.
(z-5) "Medication shopping" means the conduct prohibited under subsection (a) of Section 314.5 of this Act.
(z-10) "Mid-level practitioner" means (i) a physician assistant who has been delegated authority to prescribe through a written delegation of authority by a physician licensed to practice medicine in all of its branches, in accordance with Section 7.5 of the Physician Assistant Practice Act of 1987, (ii) an advanced practice nurse who has been delegated authority to prescribe through a written delegation of authority by a physician licensed to practice medicine in all of its branches or by a podiatric physician, in accordance with Section 65-40 of the Nurse Practice Act, or (iii) an animal euthanasia agency.
(aa) "Narcotic drug" means any of the following, whether produced
directly or indirectly by extraction from substances of vegetable origin,
or independently by means of chemical synthesis, or by a combination of
extraction and chemical synthesis:
(1) opium, opiates, derivatives of opium and opiates,
including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation; however the term "narcotic drug" does not include the isoquinoline alkaloids of opium;
(3) opium poppy and poppy straw;
(4) coca leaves, except coca leaves and extracts of
coca leaves from which substantially all of the cocaine and ecgonine, and their isomers, derivatives and salts, have been removed;
(5) cocaine, its salts, optical and geometric
isomers, and salts of isomers;
(6) ecgonine, its derivatives, their salts, isomers,
(7) any compound, mixture, or preparation which
contains any quantity of any of the substances referred to in subparagraphs (1) through (6).
(bb) "Nurse" means a registered nurse licensed under the
Nurse Practice Act.
(dd) "Opiate" means any substance having an addiction forming or
addiction sustaining liability similar to morphine or being capable of
conversion into a drug having addiction forming or addiction sustaining
(ee) "Opium poppy" means the plant of the species Papaver
somniferum L., except its seeds.
(ee-5) "Oral dosage" means a tablet, capsule, elixir, or solution or other liquid form of medication intended for administration by mouth, but the term does not include a form of medication intended for buccal, sublingual, or transmucosal administration.
(ff) "Parole and Pardon Board" means the Parole and Pardon Board of
the State of Illinois or its successor agency.
(gg) "Person" means any individual, corporation, mail-order pharmacy,
government or governmental subdivision or agency, business trust, estate,
trust, partnership or association, or any other entity.
(hh) "Pharmacist" means any person who holds a license or certificate of
registration as a registered pharmacist, a local registered pharmacist
or a registered assistant pharmacist under the Pharmacy Practice Act.
(ii) "Pharmacy" means any store, ship or other place in which
pharmacy is authorized to be practiced under the Pharmacy Practice Act.
(ii-5) "Pharmacy shopping" means the conduct prohibited under subsection (b) of Section 314.5 of this Act.
(ii-10) "Physician" (except when the context otherwise requires) means a person licensed to practice medicine in all of its branches.
(jj) "Poppy straw" means all parts, except the seeds, of the opium
poppy, after mowing.
(kk) "Practitioner" means a physician licensed to practice medicine in all
its branches, dentist, optometrist, podiatric physician,
veterinarian, scientific investigator, pharmacist, physician assistant,
advanced practice nurse,
nurse, registered nurse, hospital, laboratory, or pharmacy, or other
person licensed, registered, or otherwise lawfully permitted by the
United States or this State to distribute, dispense, conduct research
with respect to, administer or use in teaching or chemical analysis, a
controlled substance in the course of professional practice or research.
(ll) "Pre-printed prescription" means a written prescription upon which
the designated drug has been indicated prior to the time of issuance; the term does not mean a written prescription that is individually generated by machine or computer in the prescriber's office.
(mm) "Prescriber" means a physician licensed to practice medicine in all
its branches, dentist, optometrist, podiatric physician or
veterinarian who issues a prescription, a physician assistant who
prescription for a controlled substance
with Section 303.05, a written delegation, and a written supervision agreement required under Section 7.5
Physician Assistant Practice Act of 1987, or an advanced practice
nurse with prescriptive authority delegated under Section 65-40 of the Nurse Practice Act and in accordance with Section 303.05, a written delegation,
and a written
collaborative agreement under Section 65-35 of the Nurse Practice Act.
(nn) "Prescription" means a written, facsimile, or oral order, or an electronic order that complies with applicable federal requirements,
a physician licensed to practice medicine in all its branches,
dentist, podiatric physician or veterinarian for any controlled
substance, of an optometrist for a Schedule III, IV, or V controlled substance in accordance with Section 15.1 of the Illinois Optometric Practice Act of 1987, of a physician assistant for a
in accordance with Section 303.05, a written delegation, and a written supervision agreement required under
Section 7.5 of the
Physician Assistant Practice Act of 1987, or of an advanced practice
nurse with prescriptive authority delegated under Section 65-40 of the Nurse Practice Act who issues a prescription for a
controlled substance in accordance
Section 303.05, a written delegation, and a written collaborative agreement under Section 65-35 of the Nurse Practice Act when required by law.
(nn-5) "Prescription Information Library" (PIL) means an electronic library that contains reported controlled substance data.
(nn-10) "Prescription Monitoring Program" (PMP) means the entity that collects, tracks, and stores reported data on controlled substances and select drugs pursuant to Section 316.
(oo) "Production" or "produce" means manufacture, planting,
cultivating, growing, or harvesting of a controlled substance other than methamphetamine.
(pp) "Registrant" means every person who is required to register
under Section 302 of this Act.
(qq) "Registry number" means the number assigned to each person
authorized to handle controlled substances under the laws of the United
States and of this State.
(qq-5) "Secretary" means, as the context requires, either the Secretary of the Department or the Secretary of the Department of Financial and Professional Regulation, and the Secretary's designated agents.
(rr) "State" includes the State of Illinois and any state, district,
commonwealth, territory, insular possession thereof, and any area
subject to the legal authority of the United States of America.
(rr-5) "Stimulant" means any drug that (i) causes an overall excitation of central nervous system functions, (ii) causes impaired consciousness and awareness, and (iii) can be habit-forming or lead to a substance abuse problem, including but not limited to amphetamines and their analogs, methylphenidate and its analogs, cocaine, and phencyclidine and its analogs.
(ss) "Ultimate user" means a person who lawfully possesses a
controlled substance for his or her own use or for the use of a member of his or her
household or for administering to an animal owned by him or her or by a member
of his or her household.
(Source: P.A. 97-334, eff. 1-1-12; 98-214, eff. 8-9-13.)
720 ILCS 570/103
(720 ILCS 570/103)
(from Ch. 56 1/2, par. 1103)
Scope of Act.
Nothing in this Act limits the lawful authority
granted by the
Medical Practice Act of 1987, the Nurse Practice
Act, the Illinois Optometric Practice Act of 1987, or
the Pharmacy Practice Act.
(Source: P.A. 95-242, eff. 1-1-08; 95-639, eff. 10-5-07; 95-689, eff. 10-29-07; 95-876, eff. 8-21-08.)